Last reviewed · How we verify
NCT06812416
Effectiveness of Qualia NAD+ Supplementation on NAD Levels
NA trial testing Qualia NAD+ in Intracellular NAD+ Levels in 92 participants. Completed in 11 March 2024.
11 March 2024
Quick facts
| Lead sponsor | Qualia Life Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 92 |
| Start date | 24 October 2023 |
| Primary completion | 11 March 2024 |
| Estimated completion | 11 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Qualia NAD+
- Rice Flour Placebo
Conditions studied
- Intracellular NAD+ Levels — all drugs for Intracellular NAD+ Levels →
Sponsor
Qualia Life Sciences
Who can join
Adults 40 to 65, any sex, with Intracellular NAD+ Levels. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Qualia NAD+® Increases NAD+ Levels In Human Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Blomquist SA, Kelly G, Adães S, D’Adamo CR, et al · · 2025 · cited 1× · DOI 10.1101/2025.03.19.25324259
Verify or expand the search:
- PubMed search for NCT06812416
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Qualia NAD+
Trials testing the same drug.
- NCT06505967 — Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels · NA · recruiting
Other Qualia Life Sciences trials
Trials by the same sponsor.
- NCT07361757 — Qualia Perimenopause Efficacy and Tolerability Study: An Open-label 3-Arm Trial · NA · not yet recruiting
- NCT07285109 — The Impact of Qualia Vitamin C+ on Blood Vitamin C Levels · NA · recruiting
- NCT07221955 — The Impact of Qualia Gluthathione+ on Blood Glutathione Levels · NA · not yet recruiting
- NCT07132801 — Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels · NA · not yet recruiting
- NCT07156526 — Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06812416 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qualia Life Sciences
- Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06812416.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing